Cytokine gene expression profiles in human lymphocytes induced by a formula of traditional Chinese medicine, vigconic VI-28

Journal of Interferon and Cytokine Research

Volumn 26, Issue 9, 2006, Pages 628-636

  Pan Hammarström, Qiang ^a   Wen, Sicheng ^a   Hammarström, Lennart ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CD9 ANTIGEN; CHEMOKINE CXCL5; CHINESE DRUG; DISABLED 2 PROTEIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON; GROWTH RELATED PROTEIN BETA; HERBACEOUS AGENT; INTERLEUKIN 1; INTERLEUKIN 2 RECEPTOR ALPHA; SOMATOMEDIN B; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UNCLASSIFIED DRUG; VIGCONIC VI 28;

ARTICLE; CHINESE MEDICINE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; GENE EXPRESSION REGULATION; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VIVO STUDY; INNATE IMMUNITY; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION; TRADITIONAL MEDICINE;

CELLS, CULTURED; CLUSTER ANALYSIS; CYTOKINES; DRUGS, CHINESE HERBAL; GENE EXPRESSION PROFILING; HUMANS; LYMPHOCYTES; MEDICINE, CHINESE TRADITIONAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLANT PREPARATIONS; SPLEEN;

ENA; HEPATITIS B VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33750613779     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.26.628     Document Type: Article

References (49)

1. Chui SH, Chan K, Wong RN, Chen KJ. A panel study on the effects of a Chinese medicinal suppository, Vigconic VI-28, on insulin-like growth factor 1 and homocysteine in healthy men. Methods Find. Exp. Clin. Pharmacol. 2004;26:349-355.
2. Mak DH, Chiu PY, Poon MK, Ng TT, Chung YK, Lam BY, Du Y, Ko KM. A yang-promoting Chinese herbal suppository preparation enhances the antioxidant status of red cells in male human subjects. Phytother. Res. 2004;18:525-530.
3. Shin JY, Song JY, Yun YS, Yang HO, Rhee DK, Pyo S. Immunostimulating effects of acidic polysaccharides extract of Panax ginseng on macrophage function. Immunopharmacol. Immunotoxicol. 2002;24:469-482.
4. Song ZJ, Johansen HK, Faber V, Hoiby N. Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia. APMIS 1997;105:438-444.
5. Nakaya TA, Kita M, Kuriyama H, Iwakura Y, Imanishi J. Panax ginseng induces production of proinflammatory cytokines via toll-like receptor. J. Interferon Cytokine Res. 2004;24:93-100.
6. Tan BK, Vanitha J. Immunomodulatory and antimicrobial effects of some traditional chinese medicinal herbs: a review. Curr. Med. Chem. 2004;11:1423-1430.
7. Kim KM, Kwon YG, Chung HT, Yun YG, Pae HO, Han JA, Ha KS, Kim TW, Kim YM. Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-kappaB activation. Toxicol. Appl. Pharmacol. 2003;190:1-8.
8. Koh JH, Yu KW, Suh HJ, Choi YM, Ahn TS. Activation of macrophages and the intestinal immune system by an orally administered decoction from cultured mycelia of Cordyceps sinensis. Biosci. Biotechnol. Biochem. 2002;66:407-411.
9. Weng SC, Chou CJ, Lin LC, Tsai WJ, Kuo YC. Immunomodulatory functions of extracts from the Chinese medicinal fungus Cordyceps cicadae. J. Ethnopharmacol. 2002;83:79-85.
10. Gong HY, Wang KQ, Tang SG. Effects of Cordyceps sinensis on T lymphocyte subsets and hepatofibrosis in patients with chronic hepatitis B. Hunan. Yi. Ke. Da. Xue. Xue. Bao. 2000;25:248-250.
11. Rho TC, Bae EA, Kim DH, Oh WK, Kim BY, Ahn JS, Lee HS. Anti-Helicobacter pylori activity of quinolone alkaloids from Evodiae fructus. Biol. Pharm. Bull. 1999;22:1141-1143.
12. Zhang L, Wang Y, Wang LZ, Gao XM. Immunopotentiating effect of a "Yang"-promoting formula of traditional Chinese medicine on aged female BALB/c mice. Phytother. Res. 2004;18:857-861.
13. Wen S, Felley CP, Bouzourene H, Reimers M, Michetti P, Pan-Hammarström Q. Inflammatory gene profiles in gastric mucosa during Helicobacter pylori infection in humans. J. Immunol. 2004;172:2595-2606.
14. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 1998;95:14863-14868.
15. Chu DT, Wong WL, Mavligit GM. Immunotherapy with Chinese medicinal herbs. II. Reversal of cyclophosphamide-induced immune suppression by administration of fractionated Astragalus membranaceus in vivo. J. Clin. Lab. Immunol. 1988;25:125-129.
16. Chu DT, Lepe-Zuniga J, Wong WL, LaPushin R, Mavligit GM. Fractionated extract of Astragalus membranaceus, a Chinese medicinal herb, potentiates LAK cell cytotoxicity generated by a low dose of recombinant interleukin-2. J. Clin. Lab. Immunol. 1988;26:183-187.
17. Zhao KS, Mancini C, Doria G. Enhancement of the immune response in mice by Astragalus membranaceus extracts. Immunopharmacology 1990;20:225-233.
18. Sun CX, Young HW, Molina JG, Volmer JB, Schnermann J, Blackburn MR. A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. J. Clin. Invest. 2005;115:35-43.
19. Karnezis T, Mandemakers W, McQualter JL, Zheng B, Ho PP, Jordan KA, Murray BM, Barres B, Tessier-Lavigne M, Bernard CC. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat. Neurosci. 2004;7:736-744.
20. Chou CC, Pan SL, Teng CM, Guh JH. Pharmacological evaluation of several major ingredients of Chinese herbal medicines in human hepatoma Hep3B cells. Eur. J. Pharm. Sci. 2003;19:403-412.
21. Kuo YC, Weng SC, Chou CJ, Chang TT, Tsai WJ. Activation and proliferation signals in primary human T lymphocytes inhibited by ergosterol peroxide isolated from Cordyceps cicadae. Br. J. Pharmacol. 2003;140:895-906.
22. Young HA, Hardy KJ. Role of interferon-gamma in immune cell regulation. J. Leukoc. Biol. 1995;58:373-381.
23. Billiau A. Interferon-gamma: biology and role in pathogenesis. Adv. Immunol. 1996;62:61-130.
24. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu. Rev. Biochem. 1998;67:227-264.
25. Wille A, Gessner A, Lother H, Lehmann-Grube F. Mechanism of recovery from acute virus infection. VIII. Treatment of lymphocytic choriomeningitis virus-infected mice with anti-interferon-gamma monoclonal antibody blocks generation of virus-specific cytotoxic T lymphocytes and virus elimination. Eur. J. Immunol. 1989;19:1283-1288.
26. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, Zinkernagel RM, Aguet M. Functional role of type I and type II interferons in antiviral defense. Science 1994;264:1918-1921.
27. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 1993;178:2243-2247.
28. Lieberman J. Tracking the killers: how should we measure CD8 T cells in HIV infection? AIDS 2004;18:1489-1493.
29. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 1995;13:29-60.
30. Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM. Human Mig chemokine: biochemical and functional characterization. J. Exp. Med. 1995;182:1301-1314.
31. Rabin RL, Park MK, Liao F, Swofford R, Stephany D, Farber JM. Chemokine receptor responses on T cells are achieved through regulation of both receptor expression and signaling. J. Immunol. 1999;162:3840-3850.
32. Spandau U, Toksoy A, Goebeler M, Brocker EB, Gillitzer R. MIG is a dominant lymphocyte-attractant chemokine in lichen planus lesions. J. Invest. Dermatol. 1998;111:1003-1009.
33. Goebeler M, Toksoy A, Spandau U, Engelhardt E, Brocker EB, Gillitzer R. The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions. J. Pathol. 1998;184:89-95.
34. Minami Y, Kono T, Miyazaki T, Taniguchi T. The IL-2 receptor complex: its structure, function, and target genes. Annu. Rev. Immunol. 1993;11:245-268.
35. Sharfe N, Dadi HK, Shahar M, Roifman CM. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc. Natl. Acad. Sci. USA 1997;94:3168-3171.
36. Nelson BH, Willerford DM. Biology of the interleukin-2 receptor. Adv. Immunol. 1998;70:1-81.
37. Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M, Baker A, Anand-Apte B. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat. Med. 2003;9:407-415.
38. Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J. Clin. Invest. 1998;101:1478-1487.
39. 3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat. Genet. 2004;36:969-977.
40. Hocevar BA, Smine A, Xu XX, Howe PH. The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway. EMBO J. 2001;20:2789-2801.
41. Wells TN, Power CA, Lusti-Narasimhan M, Hoogewerf AJ, Cooke RM, Chung CW, Peitsch MC, Proudfoot AE. Selectivity and antagonism of chemokine receptors. J. Leukoc. Biol. 1996;59:53-60.
42. Zee-Cheng RK. Shi-quan-da-bu-tang (ten significant tonic decoction), SQT. A potent Chinese biological response modifier in cancer immunotherapy, potentiation and detoxification of anticancer drugs. Methods Find. Exp. Clin. Pharmacol. 1992;14:725-736.
43. Lee KY, Jeon YJ. Macrophage activation by polysaccharide isolated from Astragalus membranaceus. Int. Immunopharmacol. 2005;5:1225-1233.
44. Shao BM, Xu W, Dai H, Tu P, Li Z, Gao XM. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem. Biophys. Res. Commun. 2004;320:1103-1111.
45. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N. Engl. J. Med. 1991;324:1149-1155.
46. Willett B, Hosie M, Shaw A, Neil J. Inhibition of feline immunodeficiency virus infection by CD9 antibody operates after virus entry and is independent of virus tropism. J. Gen. Virol. 1997;78:611-618.
47. Loffler S, Lottspeich F, Lanza F, Azorsa DO, ter Meulen V, Schneider-Schaulies J. CD9, a tetraspan transmembrane protein, renders cells susceptible to canine distemper virus. J. Virol. 1997;71:42-49.
48. Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, McKeating JA. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J. Virol. 2004;78:1448-1455.
49. von Lindern JJ, Rojo D, Grovit-Ferbas K, Yeramian C, Deng C, Herbein G, Ferguson MR, Pappas TC, Decker JM, Singh A, Collman RG, O'Brien WA. Potential role for CD63 in CCR5-mediated human immunodeficiency virus type 1 infection of macrophages. J. Virol. 2003;77:3624-3633.